Cisatracurium Besylate Injection Usp Multidose: The Level Of The Degradation Product Benzaldehyde Is Out Of Specification In The Affected Lots.
Certain lots of Cisatracurium Besylate Injection USP Multidose contain higher than acceptable levels of a degradation product called Benzaldehyde. This is a Class I recall, meaning there is a potential health hazard. The affected product was distributed across Canada.
- Product
- CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-02-18
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/f9bfccbf-26b7-4977-9264-5a53d6313438